Bio-Rad Laboratories (BIO) Competitors $229.91 -0.28 (-0.12%) As of 11:23 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BIO vs. WAT, ILMN, TECH, CRL, BRKR, PACB, HBIO, TMO, A, and MTDShould you be buying Bio-Rad Laboratories stock or one of its competitors? The main competitors of Bio-Rad Laboratories include Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), Agilent Technologies (A), and Mettler-Toledo International (MTD). These companies are all part of the "life sciences tools & services" industry. Bio-Rad Laboratories vs. Its Competitors Waters Illumina Bio-Techne Charles River Laboratories International Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Agilent Technologies Mettler-Toledo International Bio-Rad Laboratories (NYSE:BIO) and Waters (NYSE:WAT) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, valuation, institutional ownership, profitability, analyst recommendations and community ranking. Is BIO or WAT more profitable? Waters has a net margin of 21.56% compared to Bio-Rad Laboratories' net margin of -71.86%. Waters' return on equity of 46.31% beat Bio-Rad Laboratories' return on equity.Company Net Margins Return on Equity Return on Assets Bio-Rad Laboratories-71.86% 3.90% 2.76% Waters 21.56%46.31%15.67% Which has more volatility & risk, BIO or WAT? Bio-Rad Laboratories has a beta of 0.93, indicating that its share price is 7% less volatile than the S&P 500. Comparatively, Waters has a beta of 1.11, indicating that its share price is 11% more volatile than the S&P 500. Do insiders & institutionals believe in BIO or WAT? 65.2% of Bio-Rad Laboratories shares are owned by institutional investors. Comparatively, 94.0% of Waters shares are owned by institutional investors. 17.1% of Bio-Rad Laboratories shares are owned by company insiders. Comparatively, 0.8% of Waters shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the MarketBeat Community prefer BIO or WAT? Waters received 68 more outperform votes than Bio-Rad Laboratories when rated by MarketBeat users. However, 64.60% of users gave Bio-Rad Laboratories an outperform vote while only 53.30% of users gave Waters an outperform vote. CompanyUnderperformOutperformBio-Rad LaboratoriesOutperform Votes37664.60% Underperform Votes20635.40% WatersOutperform Votes44453.30% Underperform Votes38946.70% Which has higher earnings and valuation, BIO or WAT? Waters has higher revenue and earnings than Bio-Rad Laboratories. Bio-Rad Laboratories is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBio-Rad Laboratories$2.54B2.46-$1.84B-$76.20-3.02Waters$2.98B6.90$637.83M$11.0231.39 Do analysts recommend BIO or WAT? Bio-Rad Laboratories presently has a consensus target price of $324.25, suggesting a potential upside of 41.03%. Waters has a consensus target price of $390.19, suggesting a potential upside of 12.80%. Given Bio-Rad Laboratories' stronger consensus rating and higher possible upside, equities analysts clearly believe Bio-Rad Laboratories is more favorable than Waters.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bio-Rad Laboratories 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75Waters 0 Sell rating(s) 9 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 2.61 Does the media refer more to BIO or WAT? In the previous week, Waters had 20 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 34 mentions for Waters and 14 mentions for Bio-Rad Laboratories. Waters' average media sentiment score of 0.19 beat Bio-Rad Laboratories' score of -0.11 indicating that Waters is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bio-Rad Laboratories 4 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Waters 7 Very Positive mention(s) 3 Positive mention(s) 17 Neutral mention(s) 3 Negative mention(s) 4 Very Negative mention(s) Neutral SummaryWaters beats Bio-Rad Laboratories on 15 of the 19 factors compared between the two stocks. Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIO vs. The Competition Export to ExcelMetricBio-Rad LaboratoriesAnalytical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$6.26B$4.58B$5.60B$19.86BDividend YieldN/A0.55%5.28%3.83%P/E Ratio-3.5328.6127.2335.66Price / Sales2.464.04417.6544.94Price / Cash26.9536.3438.2517.51Price / Book0.981.677.124.85Net Income-$1.84B-$84.30M$3.23B$1.02B7 Day Performance4.76%5.74%2.74%1.93%1 Month Performance-9.60%11.18%8.94%3.02%1 Year Performance-18.84%-11.38%31.59%9.84% Bio-Rad Laboratories Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIOBio-Rad Laboratories4.7107 of 5 stars$229.91-0.1%$324.25+41.0%-18.1%$6.26B$2.54B-3.538,200News CoverageAnalyst ForecastAnalyst RevisionWATWaters4.1803 of 5 stars$343.52-1.6%$390.19+13.6%+15.4%$20.44B$2.98B32.078,200Trending NewsILMNIllumina4.8988 of 5 stars$81.09-1.4%$128.15+58.0%-22.2%$12.84B$4.34B-10.5611,500Positive NewsAnalyst ForecastOptions VolumeTECHBio-Techne4.8644 of 5 stars$48.61+0.4%$72.00+48.1%-33.0%$7.62B$1.21B49.103,000CRLCharles River Laboratories International4.735 of 5 stars$134.93-0.5%$171.85+27.4%-28.2%$6.63B$4.02B899.5321,400BRKRBruker4.9598 of 5 stars$36.73+0.1%$59.10+60.9%-38.4%$5.57B$3.45B48.338,520Insider TradePACBPacific Biosciences of California2.2462 of 5 stars$0.99+2.5%$2.34+136.8%-36.3%$296.36M$152.36M-0.60730Positive NewsHBIOHarvard Bioscience3.9194 of 5 stars$0.41-13.2%$3.00+640.0%-79.1%$17.92M$91.40M-1.23490Trending NewsShort Interest ↑High Trading VolumeTMOThermo Fisher Scientific4.9756 of 5 stars$396.08-1.7%$607.43+53.4%-27.9%$149.52B$42.90B23.96130,000Positive NewsAAgilent Technologies4.6276 of 5 stars$110.92-0.9%$140.15+26.4%-9.4%$31.62B$6.51B27.3917,900Positive NewsMTDMettler-Toledo International3.7231 of 5 stars$1,138.44-1.5%$1,302.11+14.4%-17.3%$23.66B$3.83B28.0918,000Positive News Related Companies and Tools Related Companies Waters Alternatives Illumina Alternatives Bio-Techne Alternatives Charles River Laboratories International Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Thermo Fisher Scientific Alternatives Agilent Technologies Alternatives Mettler-Toledo International Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BIO) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Rad Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BIO Stock Free BIO Stock Alerts